NVO
Novo Nordisk A/SNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$196.73B
P/E Ratio
10.42
EPS
$4.26
Beta
0.35
52W High
$77.68
52W Low
$34.58
50-Day MA
$40.42
200-Day MA
$49.07
Dividend Yield
4.06%
Profit Margin
37.20%
Forward P/E
13.23
PEG Ratio
3.28
About Novo Nordisk A/S
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Fundamentals
| Revenue (TTM) | $327.80B |
| Gross Profit (TTM) | $272.72B |
| EBITDA | $173.88B |
| Operating Margin | 61.60% |
| Return on Equity | 71.40% |
| Return on Assets | 19.30% |
| Revenue/Share (TTM) | $73.77 |
| Book Value | $7.10 |
| Price-to-Book | 6.24 |
| Price-to-Sales (TTM) | 0.60 |
| EV/Revenue | 4.222 |
| EV/EBITDA | 7.69 |
| Quarterly Earnings Growth (YoY) | 67.10% |
| Quarterly Revenue Growth (YoY) | 24.00% |
| Shares Outstanding | $3.36B |
| Float | $3.19B |
| % Insiders | 0.01% |
| % Institutions | 9.87% |
Historical Volatility
HV 10-Day
25.27%
HV 20-Day
29.96%
HV 30-Day
35.28%
HV 60-Day
32.50%
HV Rank
24.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($46.67 target)
1
Strong Buy4
Buy9
HoldMore HEALTHCARE Stocks
Data last updated: 5/23/2026